Ernexa Therapeutics Inc. Comprehensive Income
Ernexa Therapeutics Inc. (ERNA) reported Comprehensive Income of -$4.44 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2021-03-11
- Ernexa Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-12-31 was $311.00K.
- Ernexa Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-09-30 was -$1.48M.
- Ernexa Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-06-30 was -$1.95M.
- Ernexa Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-03-31 was -$1.32M.
- Ernexa Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$4.44M.
- Ernexa Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$1.98M.
- Ernexa Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$404.00K.
- Ernexa Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$955.00K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$1.17M derived: sum of 2 quarters · filed 2021-03-11 | -$3.12M derived: sum of 3 quarters · filed 2021-03-11 | -$4.44M 10-K · filed 2021-03-11 | |
| 2020-09-30 | -$1.48M 10-Q · filed 2020-11-13 | -$3.43M derived: sum of 2 quarters · filed 2020-11-13 | -$4.75M 10-Q · filed 2020-11-13 | -$6.02M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2020-06-30 | -$1.95M 10-Q · filed 2020-08-07 | -$3.27M 10-Q · filed 2020-08-07 | -$4.54M derived: sum of 3 quarters · filed 2021-03-11 | -$4.91M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2020-03-31 | -$1.32M 10-Q · filed 2020-05-20 | -$2.59M derived: sum of 2 quarters · filed 2021-03-11 | -$2.96M derived: sum of 3 quarters · filed 2021-03-11 | -$3.02M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$1.64M derived: sum of 2 quarters · filed 2021-03-11 | -$1.70M derived: sum of 3 quarters · filed 2021-03-11 | -$1.98M 10-K · filed 2021-03-11 | |
| 2019-09-30 | -$369.00K 10-Q · filed 2020-11-13 | -$427.00K derived: sum of 2 quarters · filed 2020-11-13 | -$707.00K 10-Q · filed 2020-11-13 | -$748.00K derived: sum of 4 quarters · filed 2020-11-13 | |
| 2019-06-30 | -$58.00K 10-Q · filed 2020-08-07 | -$338.00K 10-Q · filed 2020-08-07 | -$379.00K derived: sum of 3 quarters · filed 2020-08-07 | -$118.00K derived: sum of 4 quarters · filed 2020-08-07 | |
| 2019-03-31 | -$280.00K 10-Q · filed 2020-05-20 | -$321.00K derived: sum of 2 quarters · filed 2020-05-20 | -$60.00K derived: sum of 3 quarters · filed 2020-05-20 | -$227.00K derived: sum of 4 quarters · filed 2020-05-20 | |
| 2018-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $220.00K derived: sum of 2 quarters · filed 2020-03-19 | $53.00K derived: sum of 3 quarters · filed 2020-03-19 | -$404.00K 10-K · filed 2020-03-19 | |
| 2018-09-30 | $261.00K 10-Q · filed 2019-11-01 | $94.00K derived: sum of 2 quarters · filed 2019-11-01 | -$363.00K 10-Q · filed 2019-11-01 | -$1.02M derived: sum of 4 quarters · filed 2019-11-01 | |
| 2018-06-30 | -$167.00K 10-Q · filed 2019-08-12 | -$624.00K 10-Q · filed 2019-08-12 | -$1.28M derived: sum of 3 quarters · filed 2019-08-12 | -$1.38M derived: sum of 4 quarters · filed 2019-08-12 | |
| 2018-03-31 | -$457.00K 10-Q · filed 2019-05-14 | -$1.11M derived: sum of 2 quarters · filed 2019-05-14 | -$1.21M derived: sum of 3 quarters · filed 2019-05-14 | -$1.34M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$653.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$757.00K derived: sum of 2 quarters · filed 2019-03-22 | -$880.00K derived: sum of 3 quarters · filed 2019-03-22 | -$955.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | -$104.00K 10-Q · filed 2018-11-09 | -$227.00K derived: sum of 2 quarters · filed 2018-11-09 | -$302.00K 10-Q · filed 2018-11-09 | -$800.00K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | -$123.00K 10-Q · filed 2018-08-06 | -$198.00K 10-Q · filed 2018-08-06 | -$696.00K derived: sum of 3 quarters · filed 2018-08-06 | -$1.29M derived: sum of 4 quarters · filed 2018-08-06 | |
| 2017-03-31 | -$75.00K 10-Q · filed 2018-05-11 | -$573.00K derived: sum of 2 quarters · filed 2018-05-11 | -$1.17M derived: sum of 3 quarters · filed 2018-05-11 | -$2.02M derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | -$498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$1.10M derived: sum of 2 quarters · filed 2018-03-09 | -$1.94M derived: sum of 3 quarters · filed 2018-03-09 | -$2.87M 10-K · filed 2018-03-09 | |
| 2016-09-30 | -$598.00K 10-Q · filed 2017-11-08 | -$1.45M derived: sum of 2 quarters · filed 2017-11-08 | -$2.37M 10-Q · filed 2017-11-08 | -$3.42M derived: sum of 4 quarters · filed 2017-11-08 | |
| 2016-06-30 | -$848.00K 10-Q · filed 2017-08-04 | -$1.78M 10-Q · filed 2017-08-04 | -$2.82M derived: sum of 3 quarters · filed 2017-08-04 | -$4.31M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | -$928.00K 10-Q · filed 2017-05-04 | -$1.97M derived: sum of 2 quarters · filed 2017-05-04 | -$3.46M derived: sum of 3 quarters · filed 2017-05-04 | -$6.04M derived: sum of 4 quarters · filed 2017-05-04 | |
| 2015-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$2.53M derived: sum of 2 quarters · filed 2017-03-09 | -$5.12M derived: sum of 3 quarters · filed 2017-03-09 | -$7.53M 10-K · filed 2017-03-09 | |
| 2015-09-30 | -$1.49M 10-Q · filed 2016-11-09 | -$4.07M derived: sum of 2 quarters · filed 2016-11-09 | -$6.49M 10-Q · filed 2016-11-09 | -$8.28M derived: sum of 4 quarters · filed 2016-11-09 | |
| 2015-06-30 | -$2.58M 10-Q · filed 2016-08-04 | -$5.00M 10-Q · filed 2016-08-04 | -$6.79M derived: sum of 3 quarters · filed 2016-08-04 | -$8.19M derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-03-31 | -$2.42M 10-Q · filed 2016-05-09 | -$4.21M derived: sum of 2 quarters · filed 2016-05-09 | -$5.61M derived: sum of 3 quarters · filed 2016-05-09 | -$6.89M derived: sum of 4 quarters · filed 2016-05-09 | |
| 2014-12-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$3.19M derived: sum of 2 quarters · filed 2016-03-15 | -$4.47M derived: sum of 3 quarters · filed 2016-03-15 | -$5.18M 10-K · filed 2016-03-15 | |
| 2014-09-30 | -$1.40M 10-Q · filed 2015-11-09 | -$2.68M derived: sum of 2 quarters · filed 2015-11-09 | -$3.39M 10-Q · filed 2015-11-09 | -$3.81M derived: sum of 4 quarters · filed 2015-11-09 | |
| 2014-06-30 | -$1.28M 10-Q · filed 2015-08-10 | -$1.99M 10-Q · filed 2015-08-10 | $1.99M 10-Q · filed 2014-08-14 | -$2.41M derived: sum of 3 quarters · filed 2015-08-10 | -$2.61M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | -$712.00K 10-Q · filed 2015-05-08 | -$1.13M derived: sum of 2 quarters · filed 2015-05-08 | -$1.33M derived: sum of 3 quarters · filed 2015-05-08 | -$1.49M derived: sum of 4 quarters · filed 2015-05-08 | |
| 2013-12-31 | -$421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$615.00K derived: sum of 2 quarters · filed 2014-11-07 | -$779.00K derived: sum of 3 quarters · filed 2014-11-07 | -$1.19M 10-K · filed 2014-03-31 | |
| 2013-09-30 | -$194.00K 10-Q · filed 2014-11-07 | -$358.00K derived: sum of 2 quarters · filed 2014-11-07 | -$769.00K 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | -$164.00K 10-Q · filed 2014-08-14 | -$575.00K 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | -$411.00K 10-Q · filed 2014-05-15 | ||||
| 2012-12-31 | -$949.00K 10-K · filed 2014-03-31 | ||||
| 2011-12-31 | -$3.48M 10-K · filed 2013-03-29 | ||||
| 2010-12-31 | -$317.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |